Pharmaceutical News

RSS

First-of-its-kind study shows antidepressants are safe

Antidepressants are safe, with adverse effects generally being due to existing psychiatric conditions, according to new research.

2 Oct 2019

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Antidepressants are generally safe, according to a new study by an international team of researchers. By assessing evidence from 45 meta-analyses, which combined the results from many studies, the researchers did not find strong evidence of adverse health outcomes associated with antidepressant use.

2 Oct 2019

Heart failure medication often prescribed in lower dosages than recommended

Important medication for the treatment of heart failure are often prescribed in lower dosages than recommended by international guidelines.

1 Oct 2019

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Researchers at the Icahn School of Medicine at Mount Sinai have received a contract award of up to $132 million from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH), as part of a new Collaborative Influenza Vaccine Innovation Centers (CIVICs) program to further develop the universal flu vaccine.

1 Oct 2019

Analyses of two clinical trials predict response to asthma drug by COPD patients

Chronic obstructive pulmonary disease, or COPD, is the third leading cause of death in the U.S., according to the American Lung Association.

30 Sep 2019

People with severe insomnia may benefit from sedatives, shows study

Insomnia is a driver of suicide, and particularly people with severe insomnia may safely benefit from taking a sedative to help address their sleep problems as it reduces their suicidal thoughts, investigators report.

30 Sep 2019

Study: Heart disease is associated with allopurinol-related severe skin reactions

Heart disease is an independent risk factor for severe adverse skin reactions in patients taking allopurinol, found a study published in CMAJ (Canadian Medical Association Journal).

30 Sep 2019

Higher dosage of statins can increase risk of osteoporosis, shows study

At low doses, statins could protect against bone resorption. But the higher the dosage of cholesterol-lowering drugs, the greater the probability of osteoporosis, an analysis of millions of patient data by the Complexity Science Hub Vienna shows.

30 Sep 2019

US Government supports Kinoxis Therapeutics to end opioid addiction

Kinoxis Therapeutics has been awarded a grant for a potential of up to $US4.6 million ($6.8 million) under the USA National Institutes of Health Helping to End Addiction Long-Term, or the NIH HEAL Initiative.

30 Sep 2019

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nintedanib, a medication approved for the treatment of idiopathic pulmonary fibrosis, slows the decline in lung function among patients with a broad range of scarring lung diseases.

30 Sep 2019

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

Eisai Co., Ltd. and Nichi-Iko Pharmaceutical have entered into a comprehensive collaboration agreement for the generic pharmaceutical business in China.

30 Sep 2019

FDA warns about Ranitidine containing known carcinogen NDMA

The United States Food and Drug Administration have issued a warning regarding some substances present in a brand of Ranitidine that could be carcinogenic. In their first warning issued on the 13th of this month, the FDA warns that one of the brands of Ranitidine, Zantac is said to contain a nitrosamine impurity called N-nitrosodimethylamine (NDMA) at low levels. NDMA is a known carcinogen, the report reads based on lab data and is also found in the environment, food and water the report adds.

26 Sep 2019

High-risk heart patients may not require long-term aspirin use after stent placement

High-risk patients undergoing coronary stent procedures may not require long-term aspirin use after stent placement, Mount Sinai researchers report in a groundbreaking study

26 Sep 2019

Arthritis drug could be used to treat lichen planus skin rash

Constant itchy, painful bumps, scaly arms and legs, and damaged nails make lichen planus an inflammatory skin disease that's both frustrating and painful for patients trying to keep their quality of life.

26 Sep 2019

Study finds nearly one in three patients with lupus uses prescription opioids for pain

Although there is little evidence that opioids effectively reduce pain from rheumatic diseases, a new study finds nearly one in three patients with lupus uses prescription opioids, often lasting longer than a year.

26 Sep 2019

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Like catching two fish with one worm, treating two problems with a single drug is efficient, but exceedingly difficult.

25 Sep 2019

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Over the years, there has been uncertainty over which drugs are best for patients with Type 2 diabetes and one of its common complications, kidney disease.

25 Sep 2019

Cheaper drug equally effective in preserving cardiovascular function in boys with DMD

A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne muscular dystrophy (DMD).

24 Sep 2019

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

Medical treatment has knocked down tumors in 6-year-old Easton Daniels' brain, but the drug used also wiped out his immune system.

24 Sep 2019

New drug delivery system could be a boon for those on a multi-drug regimen

Researchers from the University of North Carolina at Chapel Hill have developed a unique new multi-drug delivery system that could p-rove to be useful for persons who need to take several drugs in a day as part of a regimen.

23 Sep 2019

Pharmaceutical News

First-of-its-kind study shows antidepressants are safe

Researchers find no evidence of adverse health outcomes linked with antidepressant use

Heart failure medication often prescribed in lower dosages than recommended

Mount Sinai researchers receive NIH award to develop universal flu vaccine

Analyses of two clinical trials predict response to asthma drug by COPD patients

People with severe insomnia may benefit from sedatives, shows study

Study: Heart disease is associated with allopurinol-related severe skin reactions

Higher dosage of statins can increase risk of osteoporosis, shows study

US Government supports Kinoxis Therapeutics to end opioid addiction

Nintedanib drug can benefit patients with broad range of scarring lung diseases

Nichi-Iko and Eisai sign collaboration deal for generic pharmaceutical business in China

FDA warns about Ranitidine containing known carcinogen NDMA

High-risk heart patients may not require long-term aspirin use after stent placement

Arthritis drug could be used to treat lichen planus skin rash

Study finds nearly one in three patients with lupus uses prescription opioids for pain

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Study shows metformin is safe for patients with mild-to- moderate kidney disease

Cheaper drug equally effective in preserving cardiovascular function in boys with DMD

As off-label use spreads, supplies of niche drugs and patients’ patience grow short

New drug delivery system could be a boon for those on a multi-drug regimen

Edoardo Fabini

Reducing polypharmacy through innovative drug formulation technologies

How innovation in dried blood spot testing is transforming neurological disease monitoring

Latest News